Legal & General Group PLC Cytokinetics Inc Transaction History
Legal & General Group PLC
- $440 Billion
- Q2 2024
A detailed history of Legal & General Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 168,900 shares of CYTK stock, worth $8.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168,900
Previous 143,126
18.01%
Holding current value
$8.84 Million
Previous $10 Million
8.8%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$768 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$599 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$426 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$393 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$343 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.93B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...